about
Days to criterion as an indicator of toxicity associated with human Alzheimer amyloid-beta oligomersPathogenic protein seeding in Alzheimer disease and other neurodegenerative disordersAlzheimer therapeutics-what after the cholinesterase inhibitors?Inducible proteopathiesExogenous induction of cerebral beta-amyloidogenesis is governed by agent and hostLong-term hypothermia reduces infarct volume in aged rats after focal ischemiaProteomic identification of the involvement of the mitochondrial rieske protein in epilepsyNonhuman primate models of Alzheimer-like cerebral proteopathyAβ seeds resist inactivation by formaldehydeDevelopment of transgenic rats producing human beta-amyloid precursor protein as a model for Alzheimer's disease: transgene and endogenous APP genes are regulated tissue-specificallyDeficient high-affinity binding of Pittsburgh compound B in a case of Alzheimer's diseaseThe grandmother effect and the uniqueness of the human aging phenotypeMolecular polymorphism of Abeta in Alzheimer's disease.Mosaic aging.PIB binding in aged primate brain: enrichment of high-affinity sites in humans with Alzheimer's disease.Cerebral amyloid-β proteostasis is regulated by the membrane transport protein ABCC1 in miceA distinct subfraction of Aβ is responsible for the high-affinity Pittsburgh compound B-binding site in Alzheimer's disease brainKoch's postulates and infectious proteins.Automated detection of amyloid-β-related cortical and subcortical signal changes in a transgenic model of Alzheimer's disease using high-field MRI.Ovarian aging in squirrel monkeys (Saimiri sciureus).Determination of spatial and temporal distribution of microglia by 230nm-high-resolution, high-throughput automated analysis reveals different amyloid plaque populations in an APP/PS1 mouse model of Alzheimer's disease.SDS-PAGE/immunoblot detection of Abeta multimers in human cortical tissue homogenates using antigen-epitope retrieval.Soluble Aβ seeds are potent inducers of cerebral β-amyloid depositionPeripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis.Exogenous seeding of cerebral β-amyloid deposition in βAPP-transgenic rats.The presence of Aβ seeds, and not age per se, is critical to the initiation of Aβ deposition in the brainToward modeling hemorrhagic and encephalitic complications of Alzheimer amyloid-beta vaccination in nonhuman primates.Progression of Seed-Induced Aβ Deposition within the Limbic ConnectomeEmerging prospects for the disease-modifying treatment of Alzheimer's disease.Prolonged gaseous hypothermia prevents the upregulation of phagocytosis-specific protein annexin 1 and causes low-amplitude EEG activity in the aged rat brain after cerebral ischemia.Transport of cargo from periphery to brain by circulating monocytes.Corruption and spread of pathogenic proteins in neurodegenerative diseases.What amyloid ligands can tell us about molecular polymorphism and disease.The response of the aged brain to stroke: too much, too soon?Tauopathy with paired helical filaments in an aged chimpanzeeMitochondrial DNA polymorphisms specifically modify cerebral β-amyloid proteostasisClinico-pathologic function of cerebral ABC transporters - implications for the pathogenesis of Alzheimer's diseaseAlzheimer's disease and blood-brain barrier function-Why have anti-beta-amyloid therapies failed to prevent dementia progression?Induction of cerebral beta-amyloidosis: intracerebral versus systemic Abeta inoculationContext dependence of protein misfolding and structural strains in neurodegenerative diseases.
P50
Q24633883-4821044B-4E5F-411C-A369-3ED7B0DCF07AQ26850298-C00FF285-50A9-4D55-955C-27CBD4B11FFAQ28236965-F4ECCCA3-5B4A-4294-974D-7C00D5AD341BQ28249025-0C2635C8-AB9C-4672-BF61-4F73BA14241CQ28264821-D16B7C2C-5D50-4DB2-9029-0D3F29118AE7Q28568632-3B06CCF1-64B6-4CF9-B203-4E4B72AF97BFQ28578627-C4A09187-429D-4F99-89EA-5E57CBBE52A9Q28728135-B315ED99-EEE4-4AD2-87FD-F4343FAF18C5Q30587263-3A5DAFE3-10B9-49D5-9DDC-4EEF2A80B87EQ33321335-76609D05-A1D6-4853-A822-39B0D5816181Q33494855-07744E8A-B8F4-4EF8-92FE-76C651750793Q33741299-2477607A-4F0C-4CFC-87B8-67263F512DD6Q33741493-E233A667-B7C8-40D3-9176-066C17092119Q33790191-6936C42B-7053-49A1-BBB0-1AC7C57DAB36Q33936595-796E1C1D-E90D-4416-B612-CB66D855E7F0Q34212267-D7B91F3F-6E78-49CF-B140-6ECDD50AB217Q34381799-4C1EC062-5BF8-47D0-B9B6-8546FA4F62D8Q34526708-BD3FE1A8-1164-4F6A-9FFA-2AE96544354DQ34538462-5F11F977-A85C-4F38-A085-83A46BC0F035Q34995824-61F8AFE8-10E5-4E72-A9D4-B41E541D8CCEQ35050837-03CD9976-4B69-44E7-9AC6-85CFFB83CEADQ35187331-7E4ED024-52F9-4E68-8EFF-867B3BDA074FQ35588460-78B9C50E-81C4-453F-B9E3-E3BB1D685C4DQ35601755-559367EB-AAFF-46A7-BD57-628FACB8B6E7Q35800758-8285CB64-0C4A-4D71-89CB-B9381F5FC3BAQ35814796-650B9D05-6562-4929-9116-F4F8B9245500Q35876784-6B20BF3E-4418-49F4-B2A3-3898712394FDQ35931728-050AC733-2F81-4D3B-A71C-51716A01DE31Q36069185-4D442C23-98AF-4E52-AFA6-096CA37E73F3Q36170373-AB1E0248-B277-4F09-B9DF-F90F895E391CQ36274153-8CB5E9E3-BC2A-4822-BCCF-F96DCFCE8AA5Q36286068-9217411E-22CD-4EC1-BE39-B13D94D063EEQ36871202-A8020D94-3628-4C52-8CBB-6845F2DA3343Q36907379-5896688E-E8CE-4214-BB77-7FA52546B2A0Q36950153-80EC1CDB-9506-4CC6-9978-782ACF3B4C88Q36960466-2C6A4C31-DBEF-4D55-B5B6-47CCE0B4F593Q37239081-2DDFBD42-6DEC-4184-B71D-23845AA23101Q37253310-DB7F1715-77C9-46DB-AE93-2F29A47D012EQ37293239-0CDC3058-91B3-46F0-AA10-F78349F01076Q37691525-04A6620D-9859-4A18-AFB7-B5B924D5DADB
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Lary C. Walker
@ast
Lary C. Walker
@en
Lary C. Walker
@es
Lary C. Walker
@nl
Lary C. Walker
@sl
type
label
Lary C. Walker
@ast
Lary C. Walker
@en
Lary C. Walker
@es
Lary C. Walker
@nl
Lary C. Walker
@sl
prefLabel
Lary C. Walker
@ast
Lary C. Walker
@en
Lary C. Walker
@es
Lary C. Walker
@nl
Lary C. Walker
@sl
P1053
J-6541-2015
P106
P108
P1153
7402361069
P31
P3829
P496
0000-0001-9166-3261